Global Health Economics and Value Strategy Senior Director
CSL Seqirus Inc.
Disclosure(s): CSL Seqirus USA: Stocks/Bonds (Private Company)
Holds an Economics degree by Universidad del Pacifico in Lima, Peru. In addition, professor Mould-Quevedo completed a Master in Economics in Mexico at Centro de Investigación y Docencia Económicas (CIDE) and a Master in Business Administration at Paris University (Sorbonne Business School) in France. Also, holds a PhD in Applied Economics given by Universidad de Alicante in Spain. In addition, he has developed advanced courses of pharmacoeconomics at University of York in United Kingdom.
Regarding his professional experience, Dr. Mould occupied Director positions in Health Economics and Market Access for Pfizer Inc., Bayer Healthcare and CSL Seqirus Inc. He had performed over 200 Pharmacoeconomics & Outcomes Research assessments; over 90 publications of Health Economics and Outcomes Research topics in international peer-review journals and over 175 presentations at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Meetings. He had also been a manuscript reviewer for Value in Health, Pharmacoeconomics, Pan American Journal of Public Health and Vaccines Journal. Before his career in the pharmaceutical industry, he worked at the Social Security Mexican Institute as a Health Economics Researcher for two years (2003-2005) and he also was the President for 2012-2014 Health Technology Producers (Industry) Committee at the Latin American ISPOR Consortium.